Free tool
Heavily traded stocks
We cover 18 companies whose typical session turns over more than $10.00M. The median market value in the group is $30.67B. Across the group, the median move over the past trading day is +0.14%. Price change over the past year runs from +19.5% to +113.1% across the middle 80 percent of the group, with a median of +42.4%.
Other lists in this group
Table
18 of 7,336 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% |
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% |
| CSL.AX | CSL Limited | $59.72B | Large cap | −16.37% |
| BDX | Becton, Dickinson and Company | $51.81B | Large cap | +25.97% |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% |
| IQV | IQVIA Holdings Inc. | $43.04B | Large cap | +38.51% |
| ILMN | Illumina, Inc. | $33.95B | Large cap | +125.88% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +21.14% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% |
| GMAB.CO | Genmab A/S | $20.69B | Large cap | +36.19% |
| ERF.PA | Eurofins Scientific SE | $14.64B | Large cap | +15.60% |
| CRL | Charles River Laboratories International, Inc. | $14.09B | Large cap | +81.27% |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +46.30% |
| BIO | Bio-Rad Laboratories, Inc. | $10.40B | Large cap | +32.71% |
| RGEN | Repligen Corporation | $10.25B | Large cap | +51.67% |
| APGE | Apogee Therapeutics, Inc. | $10.21B | Large cap | +257.11% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.